NYSEARCA:PRF - Invesco FTSE RAFI US 1000 ETF Stock Price, News, & Analysis

Invesco FTSE RAFI US 1000 ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PRF."

News coverage about PRF stock has been trending very positive recently, InfoTrie reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Invesco FTSE RAFI US 1000 ETF earned a news impact score of 3.6 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near term.

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco FTSE RAFI US 1000 ETF investors own include Biogen (BIIB), First Trust NYSE Arca Biotechnology Index Fund (FBT), Accelerate Diagnostics (AXDX), iShares U.S. Treasury Bond ETF (GOVT), Insulet (PODD), Intellia Therapeutics (NTLA), Gulfport Energy (GPOR), Editas Medicine (EDIT), DexCom (DXCM) and Crispr Therapeutics (CRSP).

Shares of PRF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRF stock can currently be purchased for approximately $116.70.

Invesco FTSE RAFI US 1000 ETF has a market capitalization of $5.54 billion.